Details

Autor(en) / Beteiligte

• Xu, Jing
• Li, Shi-Zhu
• Guo, Jia-Gang
• Zhou, Xiao-Nong
• Djirmay, Amadou Garba

Titel

The WHO new guideline to control and eliminate human schistosomiasis: implications for the verification of transmission interruption and surveillance of Schistosoma japonicum in China

Ist Teil von

• Infectious diseases of poverty, 2022-07, Vol.11 (1), p.79-3, Article 79

Ort / Verlag

England: BioMed Central Ltd

Erscheinungsjahr

2022

Quelle

MEDLINE

Beschreibungen/Notizen

• To accelerate the achievement of United Nations’ Sustainable Development Goals, WHO published its second roadmap for NTDs in 2021 with specific targets to eliminate schistosomiasis as a public health problem in all endemic countries and interrupt the transmission in selected countries by 2030[5]. The updated public health strategy in this new guideline encourages member states to implement and integrate into national programmes to control or eliminate schistosomiasis, with following items to be strengthened: 1. i. As the target population for PC expanded from SAC to all at risk groups, various partners and donors should be ready to fill the gap between current available tablets and requirements in case of increase of PZQ need, and to provide the upcoming pediatric PZQ free of charge for the inclusion of preschool age children in PC. Individual treatment is delivered to those cases through a test-and-treat approach according to the diagnostic criteria for schistosomiasis, while preventive chemotherapy will be provided to group population at risk of infection due to their water contact behaviors in endemic settings. A loop-mediated isothermal amplification (LAMP) assay has been integrated into national surveillance activities for risk assessment due to its great advantages including high sensitivity and specificity, ease of use and cost-effectiveness when integrated with sample pooling strategy [10].